Contact
Please use this form to send email to PR contact of this press release:
Statement from HHS Secretary Becerra: 2022 Medicare Part B Premium Increase Attributable to Alzheimer’s Drug Aduhelm Will Be Adjusted and Incorporated Into Upcoming 2023 Medicare Premium Determination
TO: